245 related articles for article (PubMed ID: 15677428)
1. Mirtazapine acutely inhibits salivary cortisol concentrations in depressed patients.
Laakmann G; Hennig J; Baghai T; Schüle C
Ann N Y Acad Sci; 2004 Dec; 1032():279-82. PubMed ID: 15677428
[TBL] [Abstract][Full Text] [Related]
2. Influence of mirtazapine on salivary cortisol in depressed patients.
Laakmann G; Hennig J; Baghai T; Schüle C
Neuropsychobiology; 2003; 47(1):31-6. PubMed ID: 12606843
[TBL] [Abstract][Full Text] [Related]
3. Mirtazapine inhibits salivary cortisol concentrations in anorexia nervosa.
Schüle C; Sighart C; Hennig J; Laakmann G
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1015-9. PubMed ID: 16644086
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial.
Scharnholz B; Weber-Hamann B; Lederbogen F; Schilling C; Gilles M; Onken V; Frankhauser P; Kopf D; Deuschle M
Psychiatry Res; 2010 May; 177(1-2):109-13. PubMed ID: 20381159
[TBL] [Abstract][Full Text] [Related]
5. Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients.
Schüle C; Baghai TC; Eser D; Schwarz M; Bondy B; Rupprecht R
J Psychiatr Res; 2009 Feb; 43(5):538-45. PubMed ID: 18706658
[TBL] [Abstract][Full Text] [Related]
6. Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients.
Schüle C; Baghai TC; di Michele F; Eser D; Pasini A; Romeo E; Rupprecht R
World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):308-13. PubMed ID: 20218794
[TBL] [Abstract][Full Text] [Related]
7. Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients.
Peña S; Baccichet E; Urbina M; Carreira I; Lima L
Int Immunopharmacol; 2005 Jun; 5(6):1069-76. PubMed ID: 15829422
[TBL] [Abstract][Full Text] [Related]
8. The influence of mirtazapine on anterior pituitary hormone secretion in healthy male subjects.
Schüle C; Baghai T; Goy J; Bidlingmaier M; Strasburger C; Laakmann G
Psychopharmacology (Berl); 2002 Aug; 163(1):95-101. PubMed ID: 12185405
[TBL] [Abstract][Full Text] [Related]
9. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
[TBL] [Abstract][Full Text] [Related]
10. Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study.
Schüle C; Baghai TC; Eser D; Nothdurfter C; Rupprecht R
World J Biol Psychiatry; 2009; 10(4 Pt 2):390-9. PubMed ID: 18609420
[TBL] [Abstract][Full Text] [Related]
11. Mirtazapine for treatment-resistant depression: a preliminary report.
Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
[TBL] [Abstract][Full Text] [Related]
12. Influence of mirtazapine on urinary free cortisol excretion in depressed patients.
Schule C; Baghai T; Rackwitz C; Laakmann G
Psychiatry Res; 2003 Oct; 120(3):257-64. PubMed ID: 14561437
[TBL] [Abstract][Full Text] [Related]
13. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.
van Moffaert M; de Wilde J; Vereecken A; Dierick M; Evrard JL; Wilmotte J; Mendlewicz J
Int Clin Psychopharmacol; 1995 Mar; 10(1):3-9. PubMed ID: 7622801
[TBL] [Abstract][Full Text] [Related]
14. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.
Schüle C; Baghai TC; Eser D; Zwanzger P; Jordan M; Buechs R; Rupprecht R
Psychopharmacology (Berl); 2006 Jul; 186(4):601-11. PubMed ID: 16758243
[TBL] [Abstract][Full Text] [Related]
15. Depressed in-patients respond differently to imipramine and mirtazapine.
Bruijn JA; Moleman P; Mulder PG; van den Broek WW
Pharmacopsychiatry; 1999 May; 32(3):87-92. PubMed ID: 10463374
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine.
Schüle C; Baghai T; Zwanzger P; Ella R; Eser D; Padberg F; Möller HJ; Rupprecht R
Psychopharmacology (Berl); 2003 Mar; 166(3):271-5. PubMed ID: 12552362
[TBL] [Abstract][Full Text] [Related]
17. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
18. Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine.
Schmid DA; Wichniak A; Uhr M; Ising M; Brunner H; Held K; Weikel JC; Sonntag A; Steiger A
Neuropsychopharmacology; 2006 Apr; 31(4):832-44. PubMed ID: 16237393
[TBL] [Abstract][Full Text] [Related]
19. Cortisol metabolism in depressed patients and healthy controls.
Römer B; Lewicka S; Kopf D; Lederbogen F; Hamann B; Gilles M; Schilling C; Onken V; Frankhauser P; Deuschle M
Neuroendocrinology; 2009; 90(3):301-6. PubMed ID: 19713693
[TBL] [Abstract][Full Text] [Related]
20. The effect of mirtazapine in patients with chronic pain and concomitant depression.
Freynhagen R; Muth-Selbach U; Lipfert P; Stevens MF; Zacharowski K; Tölle TR; von Giesen HJ
Curr Med Res Opin; 2006 Feb; 22(2):257-64. PubMed ID: 16466597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
